APA (7th ed.) Citation

JA, H., PK, C., S, C., TJ, S., AC, S., K, N., . . . AM, B. (2024). Evaluation of safety and early efficacy of AAV gene therapy in mouse models of vanishing white matter disease. Molecular therapy : the journal of the American Society of Gene Therapy, 32(6), 1701. https://doi.org/10.1016/j.ymthe.2024.03.034

Chicago Style (17th ed.) Citation

JA, Herstine, et al. "Evaluation of Safety and Early Efficacy of AAV Gene Therapy in Mouse Models of Vanishing White Matter Disease." Molecular Therapy : The Journal of the American Society of Gene Therapy 32, no. 6 (2024): 1701. https://doi.org/10.1016/j.ymthe.2024.03.034.

MLA (9th ed.) Citation

JA, Herstine, et al. "Evaluation of Safety and Early Efficacy of AAV Gene Therapy in Mouse Models of Vanishing White Matter Disease." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 32, no. 6, 2024, p. 1701, https://doi.org/10.1016/j.ymthe.2024.03.034.